9/26/2013

Researchers who analyzed the DNA of 280 patients with prostate cancer found that those who had abnormal levels of disturbances at chromosomal sites that are susceptible to DNA damage had a higher risk of cancer relapse, suggesting treatment failure. If validated in larger studies, the results could lead to the development of a test to help determine the best course of treatment.

Related Summaries